Invention Grant
- Patent Title: Piperidine derivative
-
Application No.: US16079713Application Date: 2017-02-27
-
Publication No.: US10851079B2Publication Date: 2020-12-01
- Inventor: Yoshikazu Kawano , Hiroshi Shimizu , Shunpei Ishikawa , Isao Takemura , Norimitsu Hariguchi , Miki Matsuba , Makoto Matsumoto
- Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
- Applicant Address: JP Tokyo
- Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
- Current Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: JP2016-036038 20160226
- International Application: PCT/JP2017/007266 WO 20170227
- International Announcement: WO2017/146246 WO 20170831
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D405/12 ; C07D411/12 ; C07D413/12 ; C07D417/12 ; C07D471/04 ; C07D211/44 ; A61K31/498 ; A61K31/55 ; A61K31/554 ; A61K31/4725 ; A61K31/517 ; A61K31/553 ; A61K31/454 ; A61K31/4545 ; A61K31/5415 ; A61K31/4525 ; A61K31/4709 ; A61K31/536

Abstract:
The purpose of the present invention is to provide a compound having excellent antibacterial activity against mycobacterium tuberculosis, multidrug-resistant tuberculosis bacteria, and/or non-tuberculous acid-fast bacteria. A compound represented by formula [I]: (in the formula, each symbol is as described in the attached specification), or a salt thereof can be used to diagnose, prevent, and/or treat tuberculosis.
Public/Granted literature
- US20190040039A1 PIPERIDINE DERIVATIVE Public/Granted day:2019-02-07
Information query